Biocytogen Enters into Multi-Target Antibody Agreement with Neurocrine Biosciences
BEIJING & SAN DIEGO--(BUSINESS WIRE)--Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (“Biocytogen”, HKEX: 02315) today announced that it has entered into an ...
Read more